The Non-Small Cell Lung Cancer (NSCLC) market will undergo considerable growth from $5.1 billion in 2013 to $7.9 billion in 2020 at a Compound Annual Growth Rate (CAGR) of 6.6%. See more at- http://mrr.cm/Z7K

1. www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.

2. www.MarketResearchReports.com
Introduction to Report
 Launch Date: July 31, 2014
 Number of Pages: 143
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 3,500
Price For Site User License: USD 7,000
Price For Global User License: USD 10,500
Delivery Time: Within 24 Hours (During Working Days)

3. www.MarketResearchReports.com
About the Report
"Non-Small Cell Lung Cancer Market to 2020 - New
Therapies to Enhance Treatment Segmentation and Drive
Growth in an Increasingly Competitive Market" report
focuses on the increasing differentiation between the
three main NSCLC subtypes: squamous cell,
adenocarcinoma, and large cell carcinoma.
The report assesses the current NSCLC market and
predicts market trends to 2020, analyzing key drivers and
barriers.

4. www.MarketResearchReports.com
Research Finding
The value of the Non-Small Cell Lung Cancer (NSCLC)
market is expected to increase significantly over the
forecast period across the leading eight developed
nations, from $5.1 billion in 2013 to $7.9 billion in 2020.
This equates to a Compound Annual Growth Rate (CAGR)
of 6.6%. Growth will be driven by novel therapies entering
the squamous cell carcinoma market segment, which is
currently lacking effective treatment, unlike the non-
squamous market segment.
New second-line therapies include immunostimulants
such as ramucirumab and nivolumab, which have shown
clinical benefits, but which will face difficulties due to the
increasingly crowded second-line setting. Currently,
pharmaceutical treatment is limited to late-stage patients.

5. www.MarketResearchReports.com
Research Finding Continues…
Over the forecast period to 2020, several new additions
to the NSCLC treatment paradigm will transform the
treatment landscape. Many of these will be monoclonal
Antibodies (mAbs), which instigate an immune response
to the tumor rather than directly affecting cancer cells.
Squamous cell histology accounts for approximately 30%
of the NSCLC population, and pipeline products, such as
Yervoy (ipilimumab) in the first-line treatment and
nivolumab in the second-line, will add greater diversity to
the treatment algorithm, with both having shown clinical
benefits in early-stage trials.

6. www.MarketResearchReports.com
Scope
A disease introduction, which defines the disease and
looks at symptoms, diagnosis and treatment
Analysis of the NSCLC marketed landscape, including a
comparison of the efficacy and safety of the most
prominent brands, as well as the unmet needs of NSCLC
treatment
Detailed analysis of the NSCLC pipeline, covering among
other parameters, drug distribution by Phase, molecule
type and mechanism of action. The NSCLC clinical trial
landscape is analyzed with particular emphasis on failure
rates across different trial Phases, as well as the trends in
clinical trial size, duration and primary endpoint.
This section also includes profiles and single product
forecasts for the most promising pipeline drugs.

7. www.MarketResearchReports.com
Scope Continues…
An epidemiological forecast of the major NSCLC markets,
in which projected values include total and treated
populations
An in-depth forecasting model for the NSCLC market,
which considers the current marketed therapies in
addition to the potential entry of new products to the
market. The model comprises a projected outcome with
high and low variance results depending on the potential
performance of pipeline therapies.
Analysis of strategic consolidations within the NSCLC
indication, including co-development and licensing
agreements
An overview of the drivers of and barriers to the NSCLC
market

8. www.MarketResearchReports.com
Report Coverage
1. Introduction
2. Marketed Products
3. NSCLC Pipeline
4. Market Forecast
5. Strategic Consolidations
6. Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

9. www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center

10. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/Z7K
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : info@marketresearchreports.com
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)